{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:40:50Z","timestamp":1767973250577,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T00:00:00Z","timestamp":1480982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jare.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T15:26:50Z","timestamp":1481556410000},"page":"131-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hepatitis C virus and non-Hodgkin\u2019s lymphomas: A minireview"],"prefix":"10.1016","volume":"8","author":[{"given":"Hussein","family":"Khaled","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Abu-Taleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Haggag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2016.11.005_b0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2016.11.005_b0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/gut.2009.192088","article-title":"Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes","volume":"59","author":"Durand","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jare.2016.11.005_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-116-2-97","article-title":"Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study","volume":"116","author":"Simonetti","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jare.2016.11.005_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajg.2014.04.003","article-title":"The current and future disease burden of chronic hepatitis C virus infection in Egypt","volume":"15","author":"Waked","year":"2014","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.jare.2016.11.005_b0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.jare.2016.11.005_b0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","article-title":"A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt","volume":"31","author":"Sievert","year":"2011","journal-title":"Liver Int."},{"issue":"24","key":"10.1016\/j.jare.2016.11.005_b0035","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jare.2016.11.005_b0040","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ije\/dyh183","article-title":"Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt","volume":"33","author":"Cowgill","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jare.2016.11.005_b0045","article-title":"Prevalence of occult hepatitis C virus in Egyptian patients with chronic lymphoproliferative disorders","author":"Youssef","year":"2012","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.jare.2016.11.005_b0050","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.e19039","article-title":"Rituximab-induced hepatitis C virus reactivation in HCV-positive patients with diffuse large B-cell lymphoma","volume":"34","author":"Haggag","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jare.2016.11.005_b0055","first-page":"17","article-title":"Efficacy of ribavirin to prevent hepatitis reactivation in hepatitis C virus-infected patients treated for non-Hodgkin lymphoma","volume":"3","author":"Abu-Taleb","year":"2013","journal-title":"Afro-Egypt J Infect Endem Dis"},{"key":"10.1016\/j.jare.2016.11.005_b0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2016.11.005_b0065","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/gut.2009.194266","article-title":"HCV iatrogenic and intra familial transmission in Greater Cairo","volume":"59","author":"Paez Jimenez","year":"2010","journal-title":"Egypt Gut"},{"issue":"3","key":"10.1016\/j.jare.2016.11.005_b0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/molbev\/msg043","article-title":"The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach","volume":"20","author":"Pybus","year":"2003","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.jare.2016.11.005_b0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00042737-200402000-00003","article-title":"The prevalence of hepatitis C virus infection in patients with non-Hodgkin\u2019s lymphoma","volume":"16","author":"Gisbert","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2016.11.005_b0080","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jare.2016.11.005_b0085","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/hep.510260431","article-title":"Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy","volume":"26","author":"Guadagnino","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2016.11.005_b0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin\u2019s lymphoma: a meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jare.2016.11.005_b0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","article-title":"Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles","volume":"100","author":"Arcaini","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jare.2016.11.005_b0100","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/liv.12825","article-title":"Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization","volume":"35","author":"Torres","year":"2015","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jare.2016.11.005_b0105","first-page":"981","article-title":"Viral and nonviral risk factors for non-Hodgkin\u2019s lymphoma in Egypt: heterogeneity by histological and immunological subtypes","volume":"20","author":"Goldman","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.jare.2016.11.005_b0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2362.1997.1790728.x","article-title":"Viruses and cancers: possible role of hepatitis C virus","volume":"2","author":"Ferri","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jare.2016.11.005_b0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag1","year":"2013","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jare.2016.11.005_b0120","first-page":"81","article-title":"Genetic profiling of non-Hodgkin's lymphoma with or without hepatitis C virus infection","volume":"17","author":"Zekri","year":"2010","journal-title":"Egypt J Immunol"},{"issue":"1","key":"10.1016\/j.jare.2016.11.005_b0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2559.2010.03699.x","article-title":"MALT lymphoma: many roads lead to nuclear factor-\u03bab activation","volume":"58","author":"Du","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.jare.2016.11.005_b0130","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","article-title":"B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis","volume":"24","author":"Craig","year":"2010","journal-title":"Leukemia"},{"issue":"51","key":"10.1016\/j.jare.2016.11.005_b0135","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of na\u00efve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5390","key":"10.1016\/j.jare.2016.11.005_b0140","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jare.2016.11.005_b0145","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1182\/blood.V84.9.3047.3047","article-title":"Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia","volume":"84","author":"Pozzato","year":"1994","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jare.2016.11.005_b0150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jare.2016.11.005_b0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.510310230","article-title":"T (14;18) translocation in chronic hepatitis C virus infection","volume":"31","author":"Zignego","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jare.2016.11.005_b0160","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood.V99.6.2259","article-title":"Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia","volume":"99","author":"Casato","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jare.2016.11.005_b0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jare.2016.11.005_b0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.2011.08848.x","article-title":"MicroRNA expression profile in splenic marginal zone lymphoma","volume":"156","author":"Bouteloup","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jare.2016.11.005_b0175","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/leu.2012.29","article-title":"Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection","volume":"26","author":"Peveling-Oberhag","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jare.2016.11.005_b0180","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood-2012-05-402784","article-title":"The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas","volume":"120","author":"Di Lisio","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jare.2016.11.005_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","author":"Zignego","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jare.2016.11.005_b0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2016.11.005_b0195","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00004836-200404000-00011","article-title":"Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy","volume":"38","author":"Tursi","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jare.2016.11.005_b0200","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2016.11.005_b0205","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione ItalianaLinfomi","volume":"25","author":"Hosry","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jare.2016.11.005_b0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4254\/wjh.v3.i11.278","article-title":"Hepatitis C virus-related Bcell subtypes in non Hodgkin's lymphoma","volume":"3","author":"Pellicelli","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jare.2016.11.005_b0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2016.11.005_b0220","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2016.11.005_b0225","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Grouped'Etude des Lymphomes de l'Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2016.11.005_b0230","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jare.2016.11.005_b0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2008.06.025","article-title":"Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma","volume":"49","author":"La Mura","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jare.2016.11.005_b0240","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1009482","article-title":"Boceprevir for previously treated chronic HCV genotype 1 infection","volume":"364","author":"Bacon Babi\u0107","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2016.11.005_b0245","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2016.11.005_b0250","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","article-title":"Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection","volume":"360","author":"Jacobson","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2016.11.005_b0255","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2016.11.005_b0260","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the study of liver diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2016.11.005_b0265","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(96)90212-3","article-title":"Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus","volume":"347","author":"Vento","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2016.11.005_b0270","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdg363","article-title":"Hepatitis C and B-cell lymphoma","volume":"14","author":"Turner","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jare.2016.11.005_b0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrclinonc.2012.1","article-title":"Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer","volume":"9","author":"Torres","year":"2012","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216301059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216301059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:42:59Z","timestamp":1761856979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123216301059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2090123216301059"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2016.11.005","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus and non-Hodgkin\u2019s lymphomas: A minireview","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Production and hosting by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}